GoodRx Holdings, Inc. (NASDAQ: GDRX) had its price target lowered by analysts at Citigroup Inc. from $10.00 to $7.00. They now have a "buy" rating on the stock.
LowReport
GoodRx Holdings, Inc. (NASDAQ: GDRX) had its price target lowered by analysts at Citigroup Inc. from $10.00 to $7.00. They now have a "buy" rating on the stock.
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
MediumReport
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating GoodRx Holdings, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GoodRx Holdings, Inc. (NASDAQ: GDRX) had its price target lowered by analysts at Barclays PLC from $10.00 to $6.00. They now have an "overweight" rating on the stock.
LowReport
GoodRx Holdings, Inc. (NASDAQ: GDRX) had its price target lowered by analysts at Barclays PLC from $10.00 to $6.00. They now have an "overweight" rating on the stock.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: